MYC and neuroblastoma: Notwithstanding, further analysis showed that, in the same line as reported in the literature, the expression of most of the selected kinases is indeed associated with clinical features of worse prognosis, including associations with MYC amplification in NB and molecular subtypes in MB, and metastases in bone sarcomas (Supplementary Table S2).